logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

SciClone Medical (02291.HK) repurchased 12,000 shares for HK$134,500 on September 22.

date
22/09/2026
Zhito Finance APP News: Xintai Medical (02291.HK) announced that on September 22, 2026, the company spent HK$134,500 to repurchase 12,000 shares at a repurchase price of HK$11.05-11.31 per share.
Latest
2 m ago
SpaceX (SPCX.US) Halts Sales of Falcon 9 "Rideshare" Missions, Rocket Supply Shortage Triggers Space Industry Buying Spree
3 m ago
OGAWA (002614.SZ): The health service robot-related business is still in the exploratory stage.
4 m ago
KE Holdings-W (02423.HK) spent US$2.9493 million to repurchase 541,500 shares on September 21.
5 m ago
Jiurong Holdings (02358) subsidiary Jiurong New Energy received a summons issued by the People's Court of Shangcheng District, Hangzhou
5 m ago
Xinhua Winshare (00811.HK) saw its closing price deviation accumulate over 20% for three consecutive trading days; there is no material information that should be disclosed but has not been disclosed.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.